Gilead’s third acquisition since late February hands it a technology designed to make antibody-drug conjugates less toxic and ...
Stay connected via Google News In Nigeria’s tumultuous political theatre, in the build-up to the 2027 elections, ...
Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...
The ADC sounds like a new party, but it is not. It was originally formed in 2005 as the Alliance for Democratic Change, and was officially registered by the Independent National Electoral Commission ...
An EDN Design Idea (DI) presented a discussion of how to increase the resolution of an ADC by adding a non-deterministic, zero-mean, Gaussian noise dither waveform to a signal to be converted; then, ...